Philip Comp to Fibrinolytic Agents
This is a "connection" page, showing publications Philip Comp has written about Fibrinolytic Agents.
Connection Strength
0.412
-
Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery. Pharmacotherapy. 2003 Jun; 23(6):772-87.
Score: 0.207
-
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am. 2001 Mar; 83(3):336-45.
Score: 0.177
-
Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 2005 May; 3(5):962-8.
Score: 0.015
-
The activation and effects of protein C, an antithrombotic protein, in vivo. Surv Synth Pathol Res. 1984; 3(1):31-7.
Score: 0.013